According to ARK’s research, Exact Sciences has been a pioneering force in the growing field of oncology testing and will likely remain so during the next five years. Exact’s competitive advantages ...
Exact Sciences reported revenue for the third quarter that disappointed expectations and lowered its full-year guidance. The midpoint of the updated revenue guidance range is $2.74 billion, or 10% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results